These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 34453533

  • 1. Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
    Birgy A, Madhi F, Jung C, Levy C, Cointe A, Bidet P, Hobson CA, Bechet S, Sobral E, Vuthien H, Ferroni A, Aberrane S, Cuzon G, Beraud L, Gajdos V, Launay E, Pinquier D, Haas H, Desmarest M, Dommergues MA, Cohen R, Bonacorsi S, Group of the National Observatory of Urinary tract Infection due to ESBL-producing Enterobacteriaceae in children.
    J Antimicrob Chemother; 2021 Oct 11; 76(11):2839-2846. PubMed ID: 34453533
    [Abstract] [Full Text] [Related]

  • 2. In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial.
    Stewart AG, Bauer MJ, Butkiewicz D, Hinton A, Henderson A, Harris PNA, Paterson DL.
    Int J Antimicrob Agents; 2023 Aug 11; 62(2):106858. PubMed ID: 37211261
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N, Galani I, Poulakou G, Katsarolis I, Petrikkos G, Giamarellou H, Souli M.
    J Antimicrob Chemother; 2012 Oct 11; 67(10):2424-8. PubMed ID: 22665388
    [Abstract] [Full Text] [Related]

  • 5. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
    Skarp KP, Shams A, Montelin H, Lagerbäck P, Tängdén T.
    Int J Antimicrob Agents; 2019 Jan 11; 53(1):74-79. PubMed ID: 30236958
    [Abstract] [Full Text] [Related]

  • 6. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
    Birgy A, Delecourt M, Geslain G, Desselas E, Caseris M, Magnan M, Mariani-Kurkdjian P, Bidet P, Bonacorsi S.
    J Antimicrob Chemother; 2017 Jul 01; 72(7):1911-1914. PubMed ID: 28369441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
    Lignieres G, Birgy A, Jung C, Bonacorsi S, Levy C, Angoulvant F, Grimprel E, Dommergues MA, Gillet Y, Craiu I, Rybak A, De Pontual L, Dubos F, Cixous E, Gajdos V, Pinquier D, Andriantahina I, Soussan-Banini V, Georget E, Launay E, Vignaud O, Cohen R, Madhi F.
    PLoS One; 2021 Jul 01; 16(9):e0257217. PubMed ID: 34529722
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI).
    Tverring J, Månsson E, Andrews V, Ljungquist O.
    Trials; 2023 Sep 02; 24(1):568. PubMed ID: 37660037
    [Abstract] [Full Text] [Related]

  • 16. Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
    Thelen H, Dilworth TJ, Mercier RC.
    Chemotherapy; 2022 Sep 02; 67(4):261-268. PubMed ID: 36417841
    [Abstract] [Full Text] [Related]

  • 17. Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.
    Cohen Stuart J, Leverstein-Van Hall M, Kortmann W, Verlind J, Mulder F, Scharringa J, Fluit A, Ekkelenkamp M.
    Eur J Clin Microbiol Infect Dis; 2018 Oct 02; 37(10):2021-2025. PubMed ID: 30117050
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial Activity of Tebipenem and Comparators against Enterobacterales from diverse Outpatient Centers and Nursing Homes in the United States.
    Asempa TE, Bobenchik AM, Bourassa L, Clark AE, Hatch MT, Huse HK, Martin IW, Mochon AB, Munson E, Sfeir MM, Srodon M, Wang Y, Nicolau DP.
    Int J Antimicrob Agents; 2023 Mar 02; 61(3):106733. PubMed ID: 36690122
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
    François P, Croizé J, Bost C, Wollschlager K.
    Arch Pediatr; 1995 Feb 02; 2(2):136-42. PubMed ID: 7735445
    [Abstract] [Full Text] [Related]

  • 20. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM, Hope R, Mushtaq S, Warner M.
    Clin Microbiol Infect; 2008 Jan 02; 14 Suppl 1():189-93. PubMed ID: 18154546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.